1. Home
  2. AOD vs NVAX Comparison

AOD vs NVAX Comparison

Compare AOD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Total Dynamic Dividend Fund of Beneficial Interest

AOD

abrdn Total Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$9.62

Market Cap

970.0M

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOD
NVAX
Founded
2006
1987
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
970.0M
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
AOD
NVAX
Price
$9.62
$6.65
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$10.78
AVG Volume (30 Days)
423.5K
4.2M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
12.95%
N/A
EPS Growth
213.63
N/A
EPS
1.93
2.07
Revenue
$72,962,082.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
N/A
N/A
P/E Ratio
$4.44
$3.19
Revenue Growth
N/A
20.27
52 Week Low
$6.99
$5.01
52 Week High
$9.14
$11.55

Technical Indicators

Market Signals
Indicator
AOD
NVAX
Relative Strength Index (RSI) 59.37 38.44
Support Level $9.19 $6.20
Resistance Level $9.67 $7.03
Average True Range (ATR) 0.11 0.27
MACD 0.03 0.04
Stochastic Oscillator 89.69 35.32

Price Performance

Historical Comparison
AOD
NVAX

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: